Skip to main content

BANK OF MONTREAL /CAN/

Bank

Position in IBRX — ImmunityBio, Inc.

CIK 927971 TORONTO, A6

Position in IBRX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$129,729
+$109,888 QoQ
Shares Held
16,914
+68.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
15 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in IBRX Over Time

Shares Held

Position Value (USD)

Derivatives in IBRX

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$2,294,097
PutShares
299,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BANK OF MONTREAL /CAN/ holds $580,215,891 across 80 Biotechnology names. IBRX ranks #65 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IBRX

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,294,097 299,100
2026-03-31 $129,729 16,914
2025-12-31 $19,841 10,021
2025-12-31 $4,950 2,500
2025-09-30 $6,150 2,500
2025-09-30 $30,803 12,522
2025-06-30 $33,057 12,522
2025-06-30 $6,600 2,500
2025-03-31 $7,525 2,500
2025-03-31 $42,814 14,224
2024-12-31 $32,567 12,722
2024-12-31 $8,192 3,200
2024-09-30 $9,300 2,500
2024-09-30 $974,349 261,922
2024-06-30 $15,800 2,500
2024-06-30 $69,658 11,022
2024-03-31 $1,363,443 253,900
2024-03-31 $136,515 25,422
2023-12-31 $1,246,968 248,400
2023-12-31 $313,353 62,421
2023-09-30 $81,727 48,360
2023-09-30 $80,951 47,900
2023-03-31 $184,672 101,469
2023-03-31 $177,450 97,500
2022-12-31 $494,325 97,500
2022-12-31 $496,661 97,961
2022-09-30 $483,084 97,200
2022-09-30 $485,866 97,760
2021-03-31 $754,932 31,800
2021-03-31 $775,063 32,648